Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
- PMID: 20872671
- DOI: 10.1002/ijc.25236
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
Abstract
Primary central nervous system lymphomas (PCNSL) are aggressive malignancies confined to the CNS, mostly of diffuse large B-cell histotype. Despite improved understanding of the malignant B cells, little is known on the tumor microenvironment and on the response of the adaptive immunity against PCNSL. We investigated the phenotype of tumor infiltrating lymphocytes (TILs), and the expression of chemokines that could affect malignant B cells and trafficking of TILs. TILs and chemokine expression were evaluated by immunohistochemistry and in situ hybridization. Furthermore, we performed in vitro migration assays to analyze the migratory capacity of lymphocytes and malignant B cells toward chemokines and chemokine heterocomplexes. We show in 22 cases of PCNSL from immunocompetent patients that CD8(+) T cells represent the majority of TILs in the tumor mass. They tend to accumulate in perivascular areas, show Granzyme B expression and proliferate in situ. Their localization and density correlates with the expression of the inflammatory chemokine CXCL9, which is transcribed and translated by perivascular macrophages and pericytes in the perivascular microenvironment. Moreover, CXCL9 and CXCL12 are coexpressed on the tumor vasculature and form heterocomplexes. In the presence of CXCL9, CXCL12-induced migration is enhanced not only on CXCR4(+)/CXCR3(+)/CD8(+) T cells but also on CXCR4(+)/CXCR3(-) malignant B cells. These findings indicate the presence of a strong chemoattractant stimulus in the perivascular microenvironment, which might serve as regulator for the recruitment of TILs and for the angiocentric positioning of malignant B cells in the perivascular cuff.
Similar articles
-
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.Cancer Res. 2010 Dec 15;70(24):10170-81. doi: 10.1158/0008-5472.CAN-10-1943. Cancer Res. 2010. PMID: 21159639
-
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10. J Pathol. 2011. PMID: 21171080
-
Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1.Am J Clin Pathol. 2007 Apr;127(4):633-41. doi: 10.1309/NUQHJ79BHWYD9TAF. Am J Clin Pathol. 2007. PMID: 17369141
-
Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.Neuropathol Appl Neurobiol. 2010 Aug;36(5):368-87. doi: 10.1111/j.1365-2990.2010.01089.x. Epub 2010 May 6. Neuropathol Appl Neurobiol. 2010. PMID: 20487305 Review.
-
Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors.Cancer Metastasis Rev. 2019 Sep;38(3):417-430. doi: 10.1007/s10555-019-09807-3. Cancer Metastasis Rev. 2019. PMID: 31482487 Free PMC article. Review.
Cited by
-
Secreted chemokines reveal diverse inflammatory and degenerative processes in the intervertebral disc of the STZ-HFD mouse model of Type 2 diabetes.bioRxiv [Preprint]. 2024 Aug 3:2024.07.31.605332. doi: 10.1101/2024.07.31.605332. bioRxiv. 2024. PMID: 39131361 Free PMC article. Preprint.
-
Overcoming tumor resistance mechanisms in CAR-NK cell therapy.Front Immunol. 2022 Aug 3;13:953849. doi: 10.3389/fimmu.2022.953849. eCollection 2022. Front Immunol. 2022. PMID: 35990652 Free PMC article. Review.
-
Pericytes: A newly recognized player in wound healing.Wound Repair Regen. 2016 Mar;24(2):204-14. doi: 10.1111/wrr.12415. Epub 2016 Mar 10. Wound Repair Regen. 2016. PMID: 26969517 Free PMC article. Review.
-
The chemokine landscape: one system multiple shades.Front Immunol. 2023 May 11;14:1176619. doi: 10.3389/fimmu.2023.1176619. eCollection 2023. Front Immunol. 2023. PMID: 37251376 Free PMC article. Review.
-
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.J Neurooncol. 2020 Aug;149(1):13-25. doi: 10.1007/s11060-020-03580-y. Epub 2020 Jul 20. J Neurooncol. 2020. PMID: 32691208 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials